| Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised … T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ... The lancet oncology 23 (9), 1133-1144, 2022 | 166 | 2022 |
| Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma CK Falcao, MCS Cabral, JM Mota, ST Arbache, AD Costa-Riquetto, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3245-3248, 2019 | 37 | 2019 |
| Response to anti-PD1 immunotherapy in patients with metastatic cutaneous sarcoma: case reports and literature review AC Vieira, TBC Megid, R Melo, D Muniz, ACR Salgues, FG Barbosa, ... Oxford Medical Case Reports 2020 (1), omz138, 2020 | 13 | 2020 |
| The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non … G Werutsky, FC Maluf, EH Cronemberger, V Carrera Souza, ... BMC cancer 19, 1-8, 2019 | 13 | 2019 |
| Neutrophil-to-lymphocyte ratio predicts cancer outcome in locally advanced clear renal cell carcinoma MD Cordeiro, EN Ilario, DK Abe, PA de Carvalho, DQB Muniz, AS Sarkis, ... Clinical genitourinary cancer 20 (2), 102-106, 2022 | 11 | 2022 |
| A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate … FC Maluf, FA Schutz, EH Cronemberger, MA Luz, SPS Martins, ... European Journal of Cancer 158, 63-71, 2021 | 11 | 2021 |
| Prognostic value of systemic inflammatory biomarkers in patients with metastatic renal cell carcinoma G Nader Marta, P Isaacsson Velho, RRC Bonadio, M Nardo, SF Faraj, ... Pathology & Oncology Research 26, 2489-2497, 2020 | 11 | 2020 |
| Avelumab first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): Analysis of time to end of next-line therapy in … P Grivas, SH Park, E Voog, E Kopyltsov, H Gurney, DQB Muniz, F Rolland, ... Journal of Clinical Oncology 39 (15_suppl), 4525-4525, 2021 | 9 | 2021 |
| Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+ APA in patients with advanced prostate cancer … FC Maluf, AP Fay, VC Souza, FAB Schutz, O Smaletz, D Herchenhorn, ... Journal of Clinical Oncology 38 (15_suppl), 5505-5505, 2020 | 8 | 2020 |
| Analysis of efficacy and toxicity profile of first-line sunitinib or pazopanib in metastatic clear cell renal cell carcinoma in the Brazilian population P Isaacsson Velho, M Nardo, MCLA Souza, RRCC Bonadio, GN Marta, ... Journal of Global Oncology 4, JGO. 18.00073, 2018 | 7 | 2018 |
| Clinical characteristics and treatment outcomes of patients with advanced germ cell tumor treated at a Tertiary Cancer Center in Brazil VF Vasconcellos, DA Bastos, AAL Pereira, GY Watarai, BR Pereira, ... Journal of global oncology 5, 1-8, 2019 | 5 | 2019 |
| Análise biomecânica das fases da marcha por acelerómetros D Muniz, M Andrade Florianópolis: Universidade do Estado de Santa Catarina, 2011 | 4 | 2011 |
| Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic … DA Bastos, R Coelho, L Cardili, F Galiza, EN Ilario, P Viana, CB Murta, ... Journal of Clinical Oncology 40 (16_suppl), 5085-5085, 2022 | 3 | 2022 |
| Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy R Caparica, L Amorim, P Amaral, L Uratani, D Muniz, A Hendlisz, ... BMJ Supportive & Palliative Care, 2020 | 3 | 2020 |
| Real-world effectiveness and tolerability of pazopanib as first targeted therapy in metastatic renal cell carcinoma: a retrospective chart review in Latin America D Queiroz Muniz, B Ratto, H Yang, J Zhao, M Jenkins, J Signorovitch, ... Advances in Therapy 36, 3446-3457, 2019 | 3 | 2019 |
| Câncer de próstata JM MOTA, DQB MUNIZ, N CRUSOé, GF FREITAS Manual do residente de clínica médica [3. ed.], 2023 | 2 | 2023 |
| A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. FC Maluf, K Trindade, DDA Preto, FSM Monteiro, M Luz, PM Beato, ... Journal of Clinical Oncology 42 (16_suppl), 5009-5009, 2024 | 1 | 2024 |
| Non–Germ Cell Intrascrotal Tumors in Adults: A Retrospective Cohort of Localized and Metastatic Disease From a Tertiary Cancer Center MT Cunha, CA Cardoso, JA Silva, GF Freitas, DQ Muniz, GB Guglielmetti, ... JU Open Plus 1 (1), e00004, 2023 | 1 | 2023 |
| Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable? RC Bonadioa, PI Velho, GN Marta, M Nardo, MCLA Souza, DQB Muniz, ... ecancermedicalscience 13, 2019 | 1 | 2019 |
| High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil GB Polho, MT Cunha, MHM Coelho, J Almeida-Silva, CM Hidalgo Filho, ... Clinical Genitourinary Cancer, 102083, 2024 | | 2024 |
Jose Mauricio MotaInstituto do Câncer do Estado de São PauloVerified email at hc.fm.usp.br
